High Impact Publication Award, SAHMRI 2024

Prize

Description

Joint Award to Dr Laura Eadie and PhD Student Elias Lagonik for their publication: Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. Journal: Blood. 2024 Aug 29;144(9):1022-1026. doi: 10.1182/blood.2024024776.
Awarded date5 Dec 2024
Degree of recognitionLocal
Granting OrganisationsSAHMRI

Awarded at event

Event titleSAHMRI awards night
LocationSAHMRI, Adelaide, AustraliaShow on map
Period7 Dec 2017